ELIFE HLDGS (00223) announced that on January 9, 2026, the company entered into a placing agreement with a placing agent. The placing agent will undertake its best efforts to place up to 271 million new shares to no fewer than six placees at a placing price of HK$0.102 per share. The placing shares will be allotted and issued pursuant to the general mandate granted to the directors at an extraordinary general meeting. The placing shares represent approximately 16.67% of the total issued share capital as enlarged by the full allotment and issuance of the placing shares. The total nominal value of the maximum number of placing shares under the placing is HK$27.122 million. The placing price of HK$0.102 represents a discount of approximately 17.07% to the closing price of HK$0.123 per share as quoted on the Stock Exchange on the date of the placing agreement. Assuming all placing shares are successfully placed by the placing agent, the maximum gross proceeds from the placing are estimated to be approximately HK$27.6644 million, with the estimated net proceeds amounting to approximately HK$27.133 million. The company intends to use the net proceeds for developing the Group's supply chain business, repaying certain outstanding payables of the company (including professional fees and loan repayments), and supplementing the Group's working capital.